Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype

Open access
Dirscherl, Konstantin, Karlstetter, Marcus, Ebert, Stefanie, Kraus, Dominik, Hlawatsch, Julia, Walczak, Yana, Moehle, Christoph, Fuchshofer, Rudolf, Langmann, Thomas · 2010 · Journal of Neuroinflammation

Abstract

Background: Luteolin, a plant derived flavonoid, exerts a variety of pharmacological activities and anti-oxidant properties associated with its capacity to scavenge oxygen and nitrogen species. Luteolin also shows potent anti-inflammatory activities by inhibiting nuclear factor kappa B (NFkB) signaling in immune cells. To better understand the immuno-modulatory effects of this important flavonoid, we performed a genome-wide expression analysis in pro-inflammatory challenged microglia treated with luteolin and conducted a phenotypic and functional characterization. Methods: Resting and LPS-activated BV-2 microglia were treated with luteolin in various concentrations and mRNA levels of pro-inflammatory markers were determined. DNA microarray experiments and bioinformatic data mining were performed to capture global transcriptomic changes following luteolin stimulation of microglia. Extensive qRT-PCR analyses were carried out for an independent confirmation of newly identified luteolin-regulated transcripts. The activation state of luteolin-treated microglia was assessed by morphological characterization. Microglia-mediated neurotoxicity was assessed by quantifying secreted nitric oxide levels and apoptosis of 661W photoreceptors cultured in microglia-conditioned medium. Results: Luteolin dose-dependently suppressed pro-inflammatory marker expression in LPS-activated microglia and triggered global changes in the microglial transcriptome with more than 50 differentially expressed transcripts. Pro-inflammatory and pro-apoptotic gene expression was effectively blocked by luteolin. In contrast, mRNA levels of genes related to anti-oxidant metabolism, phagocytic uptake, ramification, and chemotaxis were significantly induced. Luteolin treatment had a major effect on microglial morphology leading to ramification of formerly amoeboid cells associated with the formation of long filopodia. When co-incubated with luteolin, LPS-activated microglia showed strongly reduced NO secretion and significantly decreased neurotoxicity on 661W photoreceptor cultures. Conclusions: Our findings confirm the inhibitory effects of luteolin on pro-inflammatory cytokine expression in microglia. Moreover, our transcriptomic data suggest that this flavonoid is a potent modulator of microglial activation and affects several signaling pathways leading to a unique phenotype with anti-inflammatory, anti-oxidative, and neuroprotective characteristics. With the identification of several novel luteolin-regulated genes, our findings provide a molecular basis to understand the versatile effects of luteolin on microglial homeostasis. The data also suggest that luteolin could be a promising candidate to develop immuno-modulatory and neuroprotective therapies for the treatment of neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-7-3

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 49

  1. Hanisch UK: Microglia as a source and target of cytokines. Glia. 2002, 40: 140-155. 10.1002/glia.10161. · DOI · Paper page
  2. Streit WJ: Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev. 2005, 48: 234-239. 10.1016/j.brainresrev.2004.12.013. · DOI · Paper page
  3. Giulian D, Li J, Bartel S, Broker J, Li X, Kirkpatrick JB: Cell surface morphology identifies microglia as a distinct class of mononuclear phagocyte. J Neurosci. 1995, 15: 7712-7726. · DOI
  4. Broderick C, Hoek RM, Forrester JV, Liversidge J, Sedgwick JD, Dick AD: Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol. 2002, 161: 1669-1677. · DOI · Paper page
  5. Dick AD, Carter D, Robertson M, Broderick C, Hughes E, Forrester JV, Liversidge J: Control of myeloid activity during retinal inflammation. J Leukoc Biol. 2003, 74: 161-166. 10.1189/jlb.1102535. · DOI
  6. Orr CF, Rowe DB, Halliday GM: An inflammatory review of Parkinson's disease. Prog Neurobiol. 2002, 68: 325-340. 10.1016/S0301-0082(02)00127-2. · DOI · Paper page
  7. Sargsyan SA, Monk PN, Shaw PJ: Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia. 2005, 51: 241-253. 10.1002/glia.20210. · DOI · Paper page
  8. Raivich G, Banati R: Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev. 2004, 46: 261-281. 10.1016/j.brainresrev.2004.06.006. · DOI · Paper page
  9. Langmann T: Microglia activation in retinal degeneration. J Leukoc Biol. 2007, 81: 1345-1351. 10.1189/jlb.0207114. · DOI · Paper page
  10. Schuetz E, Thanos S: Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases. Curr Drug Targets. 2004, 5: 619-627. 10.2174/1389450043345164. · DOI
  11. Hume DA: Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 2008, 1: 432-441. 10.1038/mi.2008.36. · DOI · Paper page
  12. Zhang Z, Zhang ZY, Schluesener HJ: Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol. 2009, 183: 3081-3091. 10.4049/jimmunol.0901088. · DOI
  13. Hu C, Kitts DD: Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem. 2004, 265: 107-113. 10.1023/B:MCBI.0000044364.73144.fe. · DOI · Paper page
  14. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X: Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr. 2006, 136: 1517-1521. · DOI · Paper page
  15. Chen HQ, Jin ZY, Wang XJ, Xu XM, Deng L, Zhao JW: Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett. 2008, 448: 175-179. 10.1016/j.neulet.2008.10.046. · DOI
  16. Rezai-Zadeh K, Ehrhart J, Bai Y, Sanberg PR, Bickford P, Tan J, Shytle RD: Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J Neuroinflammation. 2008, 5: 41-10.1186/1742-2094-5-41. · DOI · Paper page
  17. Jang S, Kelley KW, Johnson RW: Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA. 2008, 105: 7534-7539. 10.1073/pnas.0802865105. · DOI · Paper page
  18. Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N: Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett. 1998, 438: 220-224. 10.1016/S0014-5793(98)01304-0. · DOI · Paper page
  19. Ebert S, Schoeberl T, Walczak Y, Stoecker K, Stempfl T, Moehle C, Weber BH, Langmann T: Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. J Leukoc Biol. 2008, 84: 736-740. 10.1189/jlb.0208138. · DOI
  20. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001, 29: 365-371. 10.1038/ng1201-365. · DOI · Paper page
  21. Eichler GS, Huang S, Ingber DE: Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics. 2003, 19: 2321-2322. 10.1093/bioinformatics/btg307. · DOI · Paper page
  22. Weigelt K, Lichtinger M, Rehli M, Langmann T: Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem Biophys Res Commun. 2009, 380: 308-312. 10.1016/j.bbrc.2009.01.067. · DOI · Paper page
  23. Wegiel B, Baty CJ, Gallo D, Csizmadia E, Scott JR, Akhavan A, Chin BY, Kaczmarek E, Alam J, Bach FH, Zuckerbraun BS, Otterbein LE: Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem. 2009, 284: 21369-21378. 10.1074/jbc.M109.027433. · DOI
  24. Bea F, Hudson FN, Chait A, Kavanagh TJ, Rosenfeld ME: Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. Circ Res. 2003, 92: 386-393. 10.1161/01.RES.0000059561.65545.16. · DOI
  25. Cheng L, Han X, Shi Y: A Regulatory Role of LPCAT1 in the Synthesis of Inflammatory Lipids, PAF and LPC, in the Retina of Diabetic Mice. Am J Physiol Endocrinol Metab. 2009
  26. Koenigsknecht J, Landreth G: Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci. 2004, 24: 9838-9846. 10.1523/JNEUROSCI.2557-04.2004. · DOI · Paper page
  27. Shenoy AR, Kim BH, Choi HP, Matsuzawa T, Tiwari S, MacMicking JD: Emerging themes in IFN-gamma-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiology. 2007, 212: 771-784. 10.1016/j.imbio.2007.09.018. · DOI
  28. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E: miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA. 2009, 106: 15819-15824. 10.1073/pnas.0901216106. · DOI · Paper page
  29. Plant SR, Wang Y, Vasseur S, Thrash JC, McMahon EJ, Bergstralh DT, Arnett HA, Miller SD, Carson MJ, Iovanna JL, Ting JP: Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia. 2006, 53: 529-537. 10.1002/glia.20297. · DOI
  30. Gotoh T, Oyadomari S, Mori K, Mori M: Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem. 2002, 277: 12343-12350. 10.1074/jbc.M107988200. · DOI · Paper page
  31. Shang YY, Wang ZH, Zhang LP, Zhong M, Zhang Y, Deng JT, Zhang W: TRB3, upregulated by ox-LDL, mediates human monocyte-derived macrophage apoptosis. Febs J. 2009, 276: 2752-2761. 10.1111/j.1742-4658.2009.06998.x. · DOI
  32. Lee S, Lee J, Kim S, Park JY, Lee WH, Mori K, Kim SH, Kim IK, Suk K: A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol. 2007, 179: 3231-3241. · DOI · Paper page
  33. Granucci F, Petralia F, Urbano M, Citterio S, Di Tota F, Santambrogio L, Ricciardi-Castagnoli P: The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood. 2003, 102: 2940-2947. 10.1182/blood-2002-12-3651. · DOI
  34. Kim JS, Lee HJ, Lee MH, Kim J, Jin C, Ryu JH: Luteolin inhibits LPS-stimulated inducible nitric oxide synthase expression in BV-2 microglial cells. Planta Med. 2006, 72: 65-68. 10.1055/s-2005-873145. · DOI
  35. Al-Ubaidi MR, Font RL, Quiambao AB, Keener MJ, Liou GI, Overbeek PA, Baehr W: Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol. 1992, 119: 1681-1687. 10.1083/jcb.119.6.1681. · DOI · Paper page
  36. Ross JA, Kasum CM: Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002, 22: 19-34. 10.1146/annurev.nutr.22.111401.144957. · DOI · Paper page
  37. Seelinger G, Merfort I, Schempp CM: Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 2008, 74: 1667-1677. 10.1055/s-0028-1088314. · DOI · Paper page
  38. Lim JH, Park HS, Choi JK, Lee IS, Choi HJ: Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling. Arch Pharm Res. 2007, 30: 1590-1598. 10.1007/BF02977329. · DOI
  39. Singh A, Ling G, Suhasini AN, Zhang P, Yamamoto M, Navas-Acien A, Cosgrove G, Tuder RM, Kensler TW, Watson WH, Biswal S: Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med. 2009, 46: 376-386. 10.1016/j.freeradbiomed.2008.10.026. · DOI
  40. Osburn WO, Wakabayashi N, Misra V, Nilles T, Biswal S, Trush MA, Kensler TW: Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys. 2006, 454: 7-15. 10.1016/j.abb.2006.08.005. · DOI · Paper page
  41. de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J: Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic Biol Med. 2008, 45: 1375-1383. 10.1016/j.freeradbiomed.2008.09.001. · DOI · Paper page
  42. Harayama T, Shindou H, Ogasawara R, Suwabe A, Shimizu T: Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor. J Biol Chem. 2008, 283: 11097-11106. 10.1074/jbc.M708909200. · DOI
  43. Sheikh AM, Nagai A, Ryu JK, McLarnon JG, Kim SU, Masuda J: Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia. 2009, 57: 898-907. 10.1002/glia.20815. · DOI
  44. Stuart LM, Bell SA, Stewart CR, Silver JM, Richard J, Goss JL, Tseng AA, Zhang A, El Khoury JB, Moore KJ: CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex. J Biol Chem. 2007, 282: 27392-27401. 10.1074/jbc.M702887200. · DOI
  45. Martin CB, Ingersoll SA, Martin BK: Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets. Mol Immunol. 2007, 44: 703-712. 10.1016/j.molimm.2006.04.017. · DOI
  46. Nguyen H, Teskey L, Lin R, Hiscott J: Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation. Oncogene. 1999, 18: 5455-5463. 10.1038/sj.onc.1202924. · DOI
  47. Ramsauer K, Farlik M, Zupkovitz G, Seiser C, Kroger A, Hauser H, Decker T: Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci USA. 2007, 104: 2849-2854. 10.1073/pnas.0610944104. · DOI
  48. Zauberman A, Lapter S, Zipori D: Smad proteins suppress CCAAT/enhancer-binding protein (C/EBP) beta- and STAT3-mediated transcriptional activation of the haptoglobin promoter. J Biol Chem. 2001, 276: 24719-24725. 10.1074/jbc.M005813200. · DOI
  49. White CA, McCombe PA, Pender MP: Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int Immunol. 1998, 10: 935-941. 10.1093/intimm/10.7.935. · DOI

Cited by

See all 172

Metadata

Authors
Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y., Moehle, C., Fuchshofer, R., & Langmann, T.
Venue
Journal of Neuroinflammation
Published
2010-01-14
Volume
7
Issue
1
Pages
3-3
ISSN
1742-2094 (ISSN-L)
OpenAlex
W1967296561
Cited by
172
References
24
FWCI
8.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. https://app.cochat.ai/papers/10.1186/1742-2094-7-3
The paper
Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y., Moehle, C., Fuchshofer, R., & Langmann, T. (2010). Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-7-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.